 Sara Sawyer
Concepts (553)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Evolution, Molecular | 17 | 2021 | 454 | 4.360 |
Why?
| | Primates | 18 | 2022 | 114 | 4.180 |
Why?
| | Selection, Genetic | 18 | 2021 | 252 | 3.020 |
Why?
| | Viruses | 6 | 2023 | 96 | 3.000 |
Why?
| | Virus Replication | 13 | 2022 | 405 | 2.770 |
Why?
| | HIV-1 | 11 | 2019 | 776 | 2.200 |
Why?
| | Mutation | 27 | 2023 | 3457 | 2.100 |
Why?
| | CD4 Antigens | 5 | 2019 | 126 | 2.050 |
Why?
| | Exome | 10 | 2023 | 220 | 1.980 |
Why?
| | Host-Pathogen Interactions | 9 | 2021 | 300 | 1.810 |
Why?
| | Nuclear Proteins | 10 | 2020 | 597 | 1.670 |
Why?
| | Ubiquitin-Protein Ligases | 10 | 2019 | 148 | 1.660 |
Why?
| | Carrier Proteins | 11 | 2017 | 726 | 1.610 |
Why?
| | Viral Proteins | 7 | 2021 | 296 | 1.530 |
Why?
| | Carrier State | 2 | 2021 | 57 | 1.530 |
Why?
| | Receptors, Virus | 6 | 2019 | 78 | 1.470 |
Why?
| | Host Specificity | 5 | 2018 | 24 | 1.460 |
Why?
| | Zoonoses | 3 | 2019 | 20 | 1.440 |
Why?
| | Sequence Analysis, DNA | 10 | 2015 | 755 | 1.420 |
Why?
| | Nuclear Pore Complex Proteins | 2 | 2018 | 34 | 1.280 |
Why?
| | Genes, BRCA1 | 5 | 2015 | 31 | 1.280 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 2 | 2019 | 98 | 1.260 |
Why?
| | Saccharomyces cerevisiae | 6 | 2018 | 495 | 1.240 |
Why?
| | Tripartite Motif Proteins | 7 | 2019 | 31 | 1.160 |
Why?
| | Receptors, Transferrin | 3 | 2015 | 23 | 1.120 |
Why?
| | Animals | 50 | 2023 | 33381 | 1.100 |
Why?
| | Chiroptera | 3 | 2019 | 50 | 1.090 |
Why?
| | Influenza A Virus, H3N2 Subtype | 2 | 2023 | 39 | 1.050 |
Why?
| | Virus Internalization | 5 | 2022 | 41 | 1.050 |
Why?
| | Genomics | 7 | 2022 | 706 | 1.040 |
Why?
| | Amino Acid Sequence | 20 | 2019 | 2071 | 0.990 |
Why?
| | HIV Infections | 9 | 2019 | 2459 | 0.990 |
Why?
| | Saccharomyces cerevisiae Proteins | 6 | 2018 | 348 | 0.980 |
Why?
| | Intellectual Disability | 7 | 2023 | 136 | 0.980 |
Why?
| | Biological Evolution | 6 | 2018 | 443 | 0.970 |
Why?
| | Peptide Hydrolases | 3 | 2020 | 108 | 0.940 |
Why?
| | Genome | 2 | 2019 | 277 | 0.930 |
Why?
| | Retroelements | 2 | 2018 | 34 | 0.930 |
Why?
| | Repressor Proteins | 7 | 2023 | 377 | 0.930 |
Why?
| | Influenza in Birds | 1 | 2023 | 4 | 0.930 |
Why?
| | Polymorphism, Single Nucleotide | 14 | 2019 | 2062 | 0.920 |
Why?
| | Dog Diseases | 2 | 2023 | 44 | 0.910 |
Why?
| | Pan troglodytes | 3 | 2019 | 57 | 0.900 |
Why?
| | Saliva | 2 | 2021 | 188 | 0.900 |
Why?
| | Arterivirus | 1 | 2022 | 2 | 0.890 |
Why?
| | Hemorrhagic Fevers, Viral | 1 | 2022 | 3 | 0.890 |
Why?
| | High-Throughput Nucleotide Sequencing | 7 | 2019 | 453 | 0.890 |
Why?
| | Epidemiological Monitoring | 1 | 2023 | 49 | 0.890 |
Why?
| | Neurofibromatosis 1 | 1 | 2023 | 37 | 0.870 |
Why?
| | Cell Cycle Proteins | 5 | 2016 | 565 | 0.870 |
Why?
| | Virus Diseases | 2 | 2016 | 198 | 0.860 |
Why?
| | Rhabdomyosarcoma | 1 | 2023 | 57 | 0.850 |
Why?
| | RNA, Viral | 5 | 2021 | 572 | 0.830 |
Why?
| | Simian Immunodeficiency Virus | 2 | 2019 | 98 | 0.820 |
Why?
| | Homozygote | 3 | 2021 | 190 | 0.810 |
Why?
| | Genetic Variation | 8 | 2018 | 926 | 0.810 |
Why?
| | Humans | 90 | 2023 | 118974 | 0.790 |
Why?
| | Urogenital Abnormalities | 1 | 2021 | 48 | 0.770 |
Why?
| | Congenital Abnormalities | 1 | 2021 | 74 | 0.770 |
Why?
| | Aotidae | 3 | 2019 | 7 | 0.750 |
Why?
| | Interferon Type I | 1 | 2021 | 129 | 0.740 |
Why?
| | Wnt Proteins | 1 | 2021 | 140 | 0.740 |
Why?
| | Rare Diseases | 4 | 2023 | 113 | 0.740 |
Why?
| | Phylogeny | 11 | 2019 | 816 | 0.730 |
Why?
| | Computational Biology | 7 | 2020 | 588 | 0.730 |
Why?
| | Herpesvirus 1, Human | 3 | 2018 | 81 | 0.720 |
Why?
| | Soft Tissue Neoplasms | 2 | 2018 | 93 | 0.710 |
Why?
| | Molecular Sequence Data | 17 | 2015 | 2871 | 0.710 |
Why?
| | Mammals | 4 | 2023 | 253 | 0.710 |
Why?
| | Membrane Proteins | 3 | 2018 | 1055 | 0.700 |
Why?
| | Species Specificity | 9 | 2018 | 565 | 0.700 |
Why?
| | Virus Attachment | 2 | 2015 | 11 | 0.680 |
Why?
| | DNA-Binding Proteins | 8 | 2021 | 1346 | 0.680 |
Why?
| | Genes, BRCA2 | 4 | 2015 | 25 | 0.670 |
Why?
| | Polysaccharides | 1 | 2019 | 78 | 0.670 |
Why?
| | Arenaviruses, New World | 2 | 2015 | 3 | 0.670 |
Why?
| | Genetic Diseases, Inborn | 2 | 2015 | 46 | 0.650 |
Why?
| | Genes | 2 | 2015 | 231 | 0.640 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 464 | 0.640 |
Why?
| | Transcription Factors | 4 | 2023 | 1570 | 0.640 |
Why?
| | Hamartoma Syndrome, Multiple | 1 | 2017 | 10 | 0.630 |
Why?
| | Dengue Virus | 1 | 2018 | 31 | 0.630 |
Why?
| | BRCA1 Protein | 2 | 2014 | 57 | 0.610 |
Why?
| | HEK293 Cells | 6 | 2019 | 625 | 0.610 |
Why?
| | Leukoencephalopathies | 1 | 2017 | 32 | 0.600 |
Why?
| | DNA, Circular | 2 | 2014 | 14 | 0.600 |
Why?
| | Fibroma | 1 | 2017 | 20 | 0.600 |
Why?
| | Ribonucleoproteins | 1 | 2017 | 88 | 0.590 |
Why?
| | Kidney Diseases | 1 | 2021 | 439 | 0.580 |
Why?
| | Cell Line | 10 | 2019 | 2707 | 0.580 |
Why?
| | Influenza A virus | 4 | 2023 | 90 | 0.580 |
Why?
| | Molecular Chaperones | 1 | 2018 | 174 | 0.580 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 143 | 0.580 |
Why?
| | DNA Repair Enzymes | 1 | 2016 | 23 | 0.570 |
Why?
| | Immediate-Early Proteins | 1 | 2016 | 55 | 0.570 |
Why?
| | Kidney | 2 | 2021 | 1353 | 0.560 |
Why?
| | Exoribonucleases | 1 | 2016 | 39 | 0.560 |
Why?
| | Base Sequence | 10 | 2017 | 2159 | 0.540 |
Why?
| | Virus Physiological Phenomena | 2 | 2012 | 6 | 0.540 |
Why?
| | Lipomatosis, Multiple Symmetrical | 1 | 2015 | 1 | 0.540 |
Why?
| | Breast Neoplasms | 6 | 2015 | 1965 | 0.540 |
Why?
| | Dogs | 5 | 2023 | 371 | 0.540 |
Why?
| | Genetic Predisposition to Disease | 10 | 2020 | 2275 | 0.530 |
Why?
| | Host-Parasite Interactions | 1 | 2016 | 110 | 0.530 |
Why?
| | GTP Phosphohydrolases | 1 | 2015 | 69 | 0.520 |
Why?
| | Histones | 2 | 2017 | 552 | 0.520 |
Why?
| | Fanconi Anemia | 1 | 2014 | 12 | 0.510 |
Why?
| | DNA Repair | 3 | 2014 | 198 | 0.510 |
Why?
| | Recombination, Genetic | 3 | 2013 | 173 | 0.510 |
Why?
| | Fungal Proteins | 3 | 2006 | 130 | 0.500 |
Why?
| | Retroviridae | 5 | 2011 | 89 | 0.500 |
Why?
| | Embryonic Development | 1 | 2015 | 118 | 0.500 |
Why?
| | Multigene Family | 2 | 2013 | 200 | 0.490 |
Why?
| | Genome, Human | 7 | 2020 | 387 | 0.490 |
Why?
| | BRCA2 Protein | 1 | 2014 | 44 | 0.490 |
Why?
| | Cerebellar Ataxia | 1 | 2014 | 7 | 0.490 |
Why?
| | Ovarian Neoplasms | 5 | 2022 | 420 | 0.480 |
Why?
| | Genome, Viral | 2 | 2019 | 124 | 0.470 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 2022 | 56 | 0.470 |
Why?
| | Abnormalities, Multiple | 3 | 2023 | 181 | 0.470 |
Why?
| | Ranavirus | 1 | 2013 | 6 | 0.470 |
Why?
| | Transcriptome | 1 | 2019 | 756 | 0.460 |
Why?
| | Polymorphism, Genetic | 6 | 2014 | 642 | 0.460 |
Why?
| | Cutis Laxa | 1 | 2013 | 2 | 0.460 |
Why?
| | Elastic Tissue | 1 | 2013 | 8 | 0.460 |
Why?
| | Genes, Essential | 1 | 2013 | 22 | 0.460 |
Why?
| | Viral Tropism | 1 | 2013 | 24 | 0.460 |
Why?
| | Proteins | 3 | 2016 | 938 | 0.460 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 226 | 0.460 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 229 | 0.460 |
Why?
| | Genome, Fungal | 2 | 2018 | 30 | 0.450 |
Why?
| | Antigens, CD | 1 | 2015 | 460 | 0.450 |
Why?
| | Nervous System Diseases | 1 | 2015 | 261 | 0.420 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1323 | 0.420 |
Why?
| | Circulating Tumor DNA | 2 | 2022 | 22 | 0.420 |
Why?
| | Extracellular Matrix Proteins | 1 | 2013 | 133 | 0.420 |
Why?
| | Plasmodium knowlesi | 1 | 2011 | 1 | 0.420 |
Why?
| | Duffy Blood-Group System | 1 | 2011 | 7 | 0.410 |
Why?
| | Neurodevelopmental Disorders | 3 | 2023 | 116 | 0.410 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2018 | 372 | 0.410 |
Why?
| | Plasmodium vivax | 1 | 2011 | 6 | 0.410 |
Why?
| | Influenza, Human | 1 | 2017 | 554 | 0.410 |
Why?
| | Phenotype | 10 | 2023 | 3003 | 0.400 |
Why?
| | Genetic Testing | 5 | 2023 | 389 | 0.400 |
Why?
| | Gene Frequency | 5 | 2011 | 513 | 0.400 |
Why?
| | DNA, Viral | 1 | 2013 | 356 | 0.400 |
Why?
| | Research Design | 3 | 2014 | 969 | 0.390 |
Why?
| | Child | 19 | 2023 | 19129 | 0.390 |
Why?
| | Protein Binding | 8 | 2019 | 1975 | 0.360 |
Why?
| | Receptors, Cell Surface | 2 | 2011 | 367 | 0.350 |
Why?
| | Models, Molecular | 5 | 2017 | 1435 | 0.350 |
Why?
| | Growth Disorders | 2 | 2020 | 77 | 0.340 |
Why?
| | Microcephaly | 2 | 2020 | 54 | 0.340 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2011 | 394 | 0.330 |
Why?
| | Mutation, Missense | 4 | 2023 | 300 | 0.330 |
Why?
| | Alleles | 5 | 2014 | 832 | 0.320 |
Why?
| | Dengue | 2 | 2020 | 60 | 0.320 |
Why?
| | Facies | 4 | 2023 | 22 | 0.320 |
Why?
| | A549 Cells | 2 | 2018 | 48 | 0.320 |
Why?
| | Sequence Alignment | 4 | 2019 | 336 | 0.310 |
Why?
| | Epidemics | 2 | 2019 | 70 | 0.310 |
Why?
| | Child, Preschool | 14 | 2021 | 9491 | 0.300 |
Why?
| | Gene Duplication | 2 | 2021 | 64 | 0.300 |
Why?
| | Polymerase Chain Reaction | 4 | 2016 | 1012 | 0.300 |
Why?
| | Viral Load | 2 | 2021 | 419 | 0.300 |
Why?
| | Germ-Line Mutation | 4 | 2023 | 134 | 0.300 |
Why?
| | Saccharomyces | 1 | 2006 | 7 | 0.300 |
Why?
| | Molecular Diagnostic Techniques | 2 | 2021 | 95 | 0.290 |
Why?
| | Haplotypes | 2 | 2005 | 473 | 0.290 |
Why?
| | Canada | 3 | 2022 | 340 | 0.280 |
Why?
| | Erythrocytes | 1 | 2011 | 641 | 0.280 |
Why?
| | RNA, Messenger | 4 | 2022 | 2657 | 0.270 |
Why?
| | Protein Structure, Tertiary | 6 | 2012 | 823 | 0.270 |
Why?
| | Replication Origin | 2 | 2004 | 15 | 0.260 |
Why?
| | Genotype | 6 | 2015 | 1882 | 0.260 |
Why?
| | Endogenous Retroviruses | 1 | 2005 | 19 | 0.260 |
Why?
| | Genes, Viral | 4 | 2013 | 93 | 0.250 |
Why?
| | Nucleoside Deaminases | 1 | 2004 | 2 | 0.250 |
Why?
| | Linkage Disequilibrium | 1 | 2005 | 273 | 0.250 |
Why?
| | Female | 26 | 2023 | 61565 | 0.240 |
Why?
| | Carcinogenesis | 2 | 2016 | 182 | 0.240 |
Why?
| | DNA | 3 | 2004 | 1388 | 0.240 |
Why?
| | Tooth Abnormalities | 1 | 2023 | 11 | 0.240 |
Why?
| | Nucleic Acid Hybridization | 2 | 2003 | 193 | 0.240 |
Why?
| | Bone Diseases, Developmental | 1 | 2023 | 12 | 0.240 |
Why?
| | Codon, Terminator | 1 | 2003 | 21 | 0.240 |
Why?
| | Megalencephaly | 1 | 2023 | 15 | 0.240 |
Why?
| | Virion | 2 | 2021 | 78 | 0.240 |
Why?
| | RNA Viruses | 2 | 2019 | 28 | 0.230 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2016 | 138 | 0.230 |
Why?
| | Virology | 1 | 2023 | 20 | 0.230 |
Why?
| | Vaginal Neoplasms | 1 | 2023 | 11 | 0.230 |
Why?
| | Cafe-au-Lait Spots | 1 | 2023 | 3 | 0.230 |
Why?
| | Mice | 10 | 2021 | 15520 | 0.230 |
Why?
| | HIV | 1 | 2004 | 210 | 0.220 |
Why?
| | Orthomyxoviridae Infections | 1 | 2023 | 53 | 0.220 |
Why?
| | Alzheimer Disease | 3 | 2003 | 513 | 0.220 |
Why?
| | Macaca | 1 | 2022 | 54 | 0.220 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2023 | 125 | 0.220 |
Why?
| | Mutagenesis, Insertional | 2 | 2018 | 61 | 0.220 |
Why?
| | Birds | 1 | 2023 | 81 | 0.220 |
Why?
| | Oligonucleotides | 1 | 2003 | 140 | 0.220 |
Why?
| | Flow Cytometry | 2 | 2016 | 1085 | 0.210 |
Why?
| | Universities | 2 | 2023 | 347 | 0.210 |
Why?
| | Infant | 7 | 2021 | 8293 | 0.210 |
Why?
| | Wilms Tumor | 1 | 2023 | 69 | 0.210 |
Why?
| | Asymptomatic Infections | 1 | 2021 | 23 | 0.200 |
Why?
| | Neoplasms | 1 | 2015 | 2179 | 0.200 |
Why?
| | Ubiquitination | 2 | 2019 | 87 | 0.200 |
Why?
| | Nucleic Acid Amplification Techniques | 1 | 2021 | 38 | 0.200 |
Why?
| | Glycosylation | 2 | 2019 | 129 | 0.200 |
Why?
| | Pedigree | 4 | 2017 | 485 | 0.200 |
Why?
| | Urinary Tract | 1 | 2021 | 40 | 0.200 |
Why?
| | Macaca mulatta | 2 | 2019 | 153 | 0.200 |
Why?
| | Viral Nonstructural Proteins | 2 | 2020 | 59 | 0.190 |
Why?
| | Chromosomes, Human, X | 1 | 2021 | 58 | 0.190 |
Why?
| | Chromosome Disorders | 1 | 2021 | 39 | 0.190 |
Why?
| | Genome-Wide Association Study | 3 | 2019 | 1323 | 0.190 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2021 | 74 | 0.190 |
Why?
| | Blepharophimosis | 1 | 2020 | 4 | 0.190 |
Why?
| | Kidney Tubules | 1 | 2021 | 128 | 0.190 |
Why?
| | Crowdsourcing | 1 | 2020 | 17 | 0.190 |
Why?
| | Receptors, CCR5 | 2 | 2017 | 54 | 0.180 |
Why?
| | Databases, Genetic | 3 | 2014 | 253 | 0.180 |
Why?
| | Pandemics | 3 | 2023 | 1355 | 0.180 |
Why?
| | Specimen Handling | 1 | 2021 | 165 | 0.180 |
Why?
| | RNA Virus Infections | 1 | 2019 | 11 | 0.180 |
Why?
| | Eczema | 1 | 2020 | 85 | 0.180 |
Why?
| | DNA Primers | 2 | 2015 | 533 | 0.180 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 46 | 0.180 |
Why?
| | Male | 17 | 2021 | 57801 | 0.180 |
Why?
| | Flavivirus Infections | 1 | 2019 | 9 | 0.180 |
Why?
| | DNA Helicases | 1 | 2000 | 131 | 0.180 |
Why?
| | env Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 16 | 0.180 |
Why?
| | Developmental Disabilities | 2 | 2023 | 247 | 0.170 |
Why?
| | HIV Envelope Protein gp120 | 1 | 2019 | 60 | 0.170 |
Why?
| | Cytidine Deaminase | 2 | 2013 | 57 | 0.170 |
Why?
| | Models, Genetic | 4 | 2006 | 595 | 0.170 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2019 | 34 | 0.170 |
Why?
| | Histone Deacetylases | 1 | 2020 | 198 | 0.170 |
Why?
| | Viral Structural Proteins | 1 | 2018 | 12 | 0.170 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2019 | 139 | 0.170 |
Why?
| | Myofibromatosis | 1 | 2018 | 6 | 0.170 |
Why?
| | Ontario | 3 | 2023 | 111 | 0.170 |
Why?
| | Kidney Neoplasms | 1 | 2023 | 334 | 0.170 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 25 | 0.170 |
Why?
| | Nucleotidyltransferases | 1 | 2018 | 25 | 0.160 |
Why?
| | HIV Seropositivity | 1 | 2019 | 111 | 0.160 |
Why?
| | Alopecia | 1 | 2018 | 34 | 0.160 |
Why?
| | Sequence Homology | 1 | 2018 | 40 | 0.160 |
Why?
| | DNA, Fungal | 1 | 2018 | 69 | 0.160 |
Why?
| | DEAD Box Protein 58 | 1 | 2017 | 8 | 0.160 |
Why?
| | Exons | 2 | 2020 | 307 | 0.160 |
Why?
| | Africa | 1 | 2018 | 100 | 0.160 |
Why?
| | Young Adult | 7 | 2021 | 10793 | 0.160 |
Why?
| | SUMO-1 Protein | 1 | 2017 | 21 | 0.160 |
Why?
| | Infant, Newborn | 4 | 2018 | 5255 | 0.160 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 371 | 0.160 |
Why?
| | Acetyltransferases | 1 | 2017 | 21 | 0.150 |
Why?
| | Charcot-Marie-Tooth Disease | 1 | 2017 | 19 | 0.150 |
Why?
| | Membrane Transport Proteins | 1 | 2018 | 137 | 0.150 |
Why?
| | Hylobates | 1 | 2016 | 5 | 0.150 |
Why?
| | Callithrix | 1 | 2016 | 8 | 0.150 |
Why?
| | Pongo | 1 | 2016 | 6 | 0.150 |
Why?
| | Pathology, Molecular | 1 | 2017 | 25 | 0.150 |
Why?
| | Totivirus | 1 | 2016 | 1 | 0.150 |
Why?
| | Intelligence | 1 | 2017 | 136 | 0.150 |
Why?
| | Autism Spectrum Disorder | 2 | 2021 | 323 | 0.150 |
Why?
| | Interferons | 1 | 2017 | 151 | 0.150 |
Why?
| | Adult | 8 | 2017 | 31512 | 0.140 |
Why?
| | Brachydactyly | 1 | 2016 | 1 | 0.140 |
Why?
| | Chondroblastoma | 1 | 2016 | 4 | 0.140 |
Why?
| | Receptors, Immunologic | 1 | 2017 | 209 | 0.140 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2016 | 6 | 0.140 |
Why?
| | Spinocerebellar Ataxias | 1 | 2016 | 3 | 0.140 |
Why?
| | Dysarthria | 1 | 2016 | 9 | 0.140 |
Why?
| | Immunoprecipitation | 1 | 2016 | 161 | 0.140 |
Why?
| | Capsid | 3 | 2012 | 77 | 0.140 |
Why?
| | Sensitivity and Specificity | 1 | 2021 | 1795 | 0.140 |
Why?
| | Signal Transduction | 4 | 2015 | 4709 | 0.140 |
Why?
| | Immunoblotting | 1 | 2016 | 307 | 0.140 |
Why?
| | Filoviridae | 1 | 2015 | 6 | 0.140 |
Why?
| | Genetic Association Studies | 2 | 2015 | 371 | 0.140 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2015 | 18 | 0.140 |
Why?
| | Antiviral Agents | 2 | 2021 | 654 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2016 | 363 | 0.140 |
Why?
| | Protein Interaction Mapping | 1 | 2016 | 104 | 0.140 |
Why?
| | White Matter | 1 | 2017 | 115 | 0.140 |
Why?
| | Tuberculosis | 1 | 2018 | 240 | 0.140 |
Why?
| | Disease Resistance | 1 | 2015 | 29 | 0.130 |
Why?
| | Muscle Spasticity | 1 | 2016 | 53 | 0.130 |
Why?
| | Heat-Shock Proteins | 1 | 2016 | 129 | 0.130 |
Why?
| | Myositis Ossificans | 1 | 2015 | 7 | 0.130 |
Why?
| | Activin Receptors, Type I | 1 | 2015 | 10 | 0.130 |
Why?
| | Adolescent | 9 | 2021 | 18480 | 0.130 |
Why?
| | Molecular Docking Simulation | 1 | 2015 | 101 | 0.130 |
Why?
| | Hallux Valgus | 1 | 2015 | 28 | 0.130 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2014 | 9 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2017 | 3174 | 0.130 |
Why?
| | Acclimatization | 1 | 2016 | 135 | 0.130 |
Why?
| | Colorado | 2 | 2023 | 4196 | 0.130 |
Why?
| | Craniofacial Abnormalities | 1 | 2015 | 58 | 0.130 |
Why?
| | Ribosomes | 1 | 2015 | 142 | 0.130 |
Why?
| | Blotting, Western | 2 | 2016 | 1194 | 0.130 |
Why?
| | Vesicle-Associated Membrane Protein 1 | 1 | 2014 | 2 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2021 | 628 | 0.130 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 404 | 0.130 |
Why?
| | HIV-2 | 1 | 2014 | 15 | 0.120 |
Why?
| | Monomeric GTP-Binding Proteins | 1 | 2014 | 6 | 0.120 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 195 | 0.120 |
Why?
| | Gene Rearrangement | 1 | 2015 | 141 | 0.120 |
Why?
| | Sarcoma | 1 | 2016 | 137 | 0.120 |
Why?
| | Syndrome | 1 | 2015 | 344 | 0.120 |
Why?
| | Transfection | 1 | 2016 | 888 | 0.120 |
Why?
| | Gene Expression | 2 | 2011 | 1489 | 0.120 |
Why?
| | Morphogenesis | 1 | 2015 | 167 | 0.120 |
Why?
| | Siblings | 1 | 2015 | 235 | 0.120 |
Why?
| | Hemiplegia | 1 | 2014 | 19 | 0.120 |
Why?
| | Dystonic Disorders | 1 | 2014 | 17 | 0.120 |
Why?
| | Chromosome Mapping | 3 | 2005 | 510 | 0.120 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2015 | 101 | 0.120 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2014 | 46 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1052 | 0.120 |
Why?
| | Consanguinity | 1 | 2014 | 49 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2016 | 199 | 0.120 |
Why?
| | Botulinum Toxins | 1 | 2014 | 40 | 0.120 |
Why?
| | Peer Review, Research | 1 | 2014 | 35 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 3 | 2004 | 103 | 0.120 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 446 | 0.120 |
Why?
| | Gene Library | 1 | 2013 | 127 | 0.120 |
Why?
| | Nervous System Malformations | 1 | 2013 | 33 | 0.110 |
Why?
| | Adaptation, Biological | 1 | 2013 | 57 | 0.110 |
Why?
| | Brain | 3 | 2015 | 2490 | 0.110 |
Why?
| | Middle Aged | 5 | 2017 | 27617 | 0.110 |
Why?
| | Amphibians | 1 | 2013 | 49 | 0.110 |
Why?
| | Neoplasm Recurrence, Local | 3 | 2023 | 900 | 0.110 |
Why?
| | Parvovirus, Canine | 1 | 2012 | 1 | 0.110 |
Why?
| | Canidae | 1 | 2012 | 1 | 0.110 |
Why?
| | Parvoviridae Infections | 1 | 2012 | 11 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2016 | 336 | 0.110 |
Why?
| | DNA Mutational Analysis | 4 | 2014 | 381 | 0.110 |
Why?
| | Hospitalization | 1 | 2021 | 1785 | 0.110 |
Why?
| | mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 28 | 0.110 |
Why?
| | Endoribonucleases | 2 | 2022 | 64 | 0.100 |
Why?
| | Cluster Analysis | 1 | 2013 | 481 | 0.100 |
Why?
| | Family Health | 1 | 2012 | 201 | 0.100 |
Why?
| | Chordata | 1 | 2011 | 5 | 0.100 |
Why?
| | Iron | 1 | 2013 | 248 | 0.100 |
Why?
| | Gene Dosage | 1 | 2011 | 136 | 0.100 |
Why?
| | DNA Polymerase beta | 1 | 2010 | 5 | 0.100 |
Why?
| | Retroviridae Infections | 2 | 2009 | 46 | 0.100 |
Why?
| | Endonucleases | 1 | 2010 | 31 | 0.100 |
Why?
| | Immunity, Innate | 2 | 2018 | 745 | 0.100 |
Why?
| | Lung | 1 | 2023 | 3664 | 0.100 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2010 | 30 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 338 | 0.090 |
Why?
| | Epilepsy | 1 | 2014 | 290 | 0.090 |
Why?
| | Endodeoxyribonucleases | 1 | 2010 | 60 | 0.090 |
Why?
| | Fetal Growth Retardation | 1 | 2015 | 468 | 0.090 |
Why?
| | Gene Conversion | 1 | 1989 | 7 | 0.090 |
Why?
| | Vero Cells | 2 | 2019 | 69 | 0.090 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3730 | 0.090 |
Why?
| | Genetic Techniques | 1 | 1989 | 60 | 0.090 |
Why?
| | Pregnancy | 1 | 2021 | 5691 | 0.090 |
Why?
| | Rodentia | 1 | 2009 | 47 | 0.080 |
Why?
| | Survival Rate | 1 | 2013 | 1720 | 0.080 |
Why?
| | Statistics as Topic | 1 | 1989 | 307 | 0.080 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2851 | 0.080 |
Why?
| | Estrogens | 1 | 2011 | 328 | 0.080 |
Why?
| | Chromosome Deletion | 2 | 2021 | 95 | 0.080 |
Why?
| | Reverse Transcription | 1 | 2007 | 19 | 0.080 |
Why?
| | Algorithms | 1 | 2015 | 1541 | 0.080 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2007 | 41 | 0.080 |
Why?
| | Binding Sites | 1 | 2010 | 1224 | 0.080 |
Why?
| | Minichromosome Maintenance Proteins | 2 | 2004 | 3 | 0.080 |
Why?
| | Genetics, Population | 2 | 2006 | 207 | 0.070 |
Why?
| | Meiosis | 1 | 2006 | 60 | 0.070 |
Why?
| | Students | 2 | 2023 | 509 | 0.070 |
Why?
| | Genomic Instability | 1 | 2006 | 38 | 0.070 |
Why?
| | Adaptation, Physiological | 1 | 2010 | 502 | 0.070 |
Why?
| | Prospective Studies | 3 | 2023 | 6471 | 0.070 |
Why?
| | Biomarkers, Tumor | 2 | 2022 | 1059 | 0.070 |
Why?
| | Point Mutation | 2 | 2018 | 228 | 0.060 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2004 | 20 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2013 | 1774 | 0.060 |
Why?
| | Cattle | 1 | 2007 | 978 | 0.060 |
Why?
| | APOBEC-1 Deaminase | 1 | 2004 | 5 | 0.060 |
Why?
| | APOBEC-3G Deaminase | 1 | 2004 | 6 | 0.060 |
Why?
| | APOBEC Deaminases | 1 | 2004 | 4 | 0.060 |
Why?
| | vif Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 4 | 0.060 |
Why?
| | Gene Products, vif | 1 | 2004 | 2 | 0.060 |
Why?
| | Cats | 2 | 2019 | 205 | 0.060 |
Why?
| | RNA Editing | 1 | 2004 | 22 | 0.060 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 2 | 2000 | 4 | 0.060 |
Why?
| | Likelihood Functions | 1 | 2004 | 136 | 0.060 |
Why?
| | rab5 GTP-Binding Proteins | 1 | 2023 | 7 | 0.060 |
Why?
| | DNA Transposable Elements | 1 | 2004 | 102 | 0.060 |
Why?
| | Catalysis | 1 | 2004 | 295 | 0.060 |
Why?
| | False Positive Reactions | 1 | 2003 | 115 | 0.060 |
Why?
| | Risk Factors | 3 | 2012 | 9000 | 0.060 |
Why?
| | rab GTP-Binding Proteins | 1 | 2023 | 64 | 0.060 |
Why?
| | Plant Viruses | 1 | 2003 | 7 | 0.060 |
Why?
| | Sequence Deletion | 1 | 2003 | 171 | 0.060 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2004 | 224 | 0.060 |
Why?
| | Monkeypox virus | 1 | 2022 | 12 | 0.050 |
Why?
| | Muscle Proteins | 1 | 2004 | 219 | 0.050 |
Why?
| | Masks | 1 | 2023 | 48 | 0.050 |
Why?
| | Genetic Markers | 1 | 2003 | 348 | 0.050 |
Why?
| | Cytoplasm | 1 | 2022 | 269 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 256 | 0.050 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2022 | 94 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2021 | 89 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 4 | 1 | 2000 | 1 | 0.050 |
Why?
| | Minichromosome Maintenance Complex Component 3 | 1 | 2000 | 2 | 0.050 |
Why?
| | Attitude | 1 | 2023 | 231 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2003 | 770 | 0.050 |
Why?
| | Haploinsufficiency | 1 | 2021 | 47 | 0.050 |
Why?
| | Arachis | 1 | 2003 | 152 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2007 | 1597 | 0.050 |
Why?
| | Oligopeptides | 1 | 2022 | 252 | 0.050 |
Why?
| | B-Lymphocytes | 1 | 2006 | 770 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 253 | 0.050 |
Why?
| | Dimerization | 1 | 2000 | 183 | 0.050 |
Why?
| | Knowledge Bases | 1 | 2020 | 24 | 0.050 |
Why?
| | Geminiviridae | 1 | 1999 | 1 | 0.050 |
Why?
| | Retrospective Studies | 2 | 2014 | 12978 | 0.050 |
Why?
| | Caenorhabditis elegans | 1 | 2023 | 287 | 0.050 |
Why?
| | Catalytic Domain | 1 | 2000 | 206 | 0.050 |
Why?
| | DNA Copy Number Variations | 1 | 2020 | 167 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 434 | 0.040 |
Why?
| | Histone Acetyltransferases | 1 | 2020 | 53 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 322 | 0.040 |
Why?
| | Flavivirus | 1 | 2019 | 16 | 0.040 |
Why?
| | HeLa Cells | 1 | 2000 | 583 | 0.040 |
Why?
| | Skull | 1 | 2020 | 127 | 0.040 |
Why?
| | Cloning, Molecular | 2 | 2011 | 546 | 0.040 |
Why?
| | Philippines | 1 | 2018 | 55 | 0.040 |
Why?
| | Nucleotides, Cyclic | 1 | 2018 | 15 | 0.040 |
Why?
| | Proteolysis | 1 | 2019 | 146 | 0.040 |
Why?
| | DNA Replication | 1 | 2000 | 211 | 0.040 |
Why?
| | Substrate Specificity | 1 | 2019 | 371 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 2003 | 1868 | 0.040 |
Why?
| | Genes, Recessive | 1 | 2018 | 73 | 0.040 |
Why?
| | Capsid Proteins | 2 | 2012 | 70 | 0.040 |
Why?
| | Age Distribution | 1 | 2018 | 362 | 0.040 |
Why?
| | Encephalitis, Viral | 1 | 1997 | 44 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1419 | 0.040 |
Why?
| | Herpes Simplex | 1 | 1997 | 90 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1244 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 539 | 0.040 |
Why?
| | Machine Learning | 1 | 2020 | 331 | 0.040 |
Why?
| | Langer-Giedion Syndrome | 1 | 2016 | 2 | 0.040 |
Why?
| | DNA Methylation | 1 | 2021 | 503 | 0.040 |
Why?
| | Hair Diseases | 1 | 2016 | 6 | 0.040 |
Why?
| | Cycloheximide | 1 | 2015 | 57 | 0.030 |
Why?
| | Nose | 1 | 2016 | 58 | 0.030 |
Why?
| | Dendritic Cells | 1 | 2019 | 442 | 0.030 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2015 | 47 | 0.030 |
Why?
| | Methyltransferases | 1 | 2016 | 61 | 0.030 |
Why?
| | Methylation | 1 | 2016 | 204 | 0.030 |
Why?
| | Fingers | 1 | 2016 | 83 | 0.030 |
Why?
| | Methionine | 1 | 2016 | 145 | 0.030 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2016 | 51 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 14 | 0.030 |
Why?
| | Codon | 1 | 2015 | 89 | 0.030 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2015 | 28 | 0.030 |
Why?
| | Population Surveillance | 1 | 2018 | 413 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2018 | 2680 | 0.030 |
Why?
| | RNA, Transfer | 1 | 2015 | 119 | 0.030 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2015 | 48 | 0.030 |
Why?
| | Thyroid Gland | 1 | 2015 | 84 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1390 | 0.030 |
Why?
| | SAM Domain and HD Domain-Containing Protein 1 | 1 | 2014 | 4 | 0.030 |
Why?
| | Deoxyribonucleotides | 1 | 2014 | 17 | 0.030 |
Why?
| | Diaphragm | 1 | 2014 | 36 | 0.030 |
Why?
| | Nucleosomes | 1 | 2016 | 131 | 0.030 |
Why?
| | Myopathies, Structural, Congenital | 1 | 2014 | 6 | 0.030 |
Why?
| | Paresis | 1 | 2014 | 31 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 3443 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2015 | 287 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 248 | 0.030 |
Why?
| | Long Interspersed Nucleotide Elements | 1 | 2014 | 23 | 0.030 |
Why?
| | Interferon-gamma | 1 | 1997 | 736 | 0.030 |
Why?
| | Financing, Organized | 1 | 2014 | 34 | 0.030 |
Why?
| | Uterus | 1 | 2015 | 194 | 0.030 |
Why?
| | Time Factors | 1 | 2004 | 6412 | 0.030 |
Why?
| | RING Finger Domains | 1 | 2013 | 2 | 0.030 |
Why?
| | Cytokines | 1 | 2021 | 1900 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2014 | 164 | 0.030 |
Why?
| | Rats | 2 | 2014 | 5392 | 0.030 |
Why?
| | Loss of Heterozygosity | 1 | 2013 | 40 | 0.030 |
Why?
| | Brain Diseases | 1 | 2014 | 140 | 0.030 |
Why?
| | Receptors, CXCR4 | 1 | 2013 | 81 | 0.030 |
Why?
| | Fibroblasts | 1 | 2017 | 842 | 0.030 |
Why?
| | Transferrin | 1 | 2012 | 39 | 0.030 |
Why?
| | Risk | 1 | 2015 | 853 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 4552 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 1992 | 22 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 276 | 0.030 |
Why?
| | CHO Cells | 1 | 2012 | 143 | 0.030 |
Why?
| | Motor Neurons | 1 | 2014 | 213 | 0.030 |
Why?
| | Erythropoiesis | 1 | 1992 | 33 | 0.030 |
Why?
| | Cricetinae | 1 | 2012 | 262 | 0.030 |
Why?
| | Penetrance | 1 | 2011 | 27 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2018 | 4908 | 0.030 |
Why?
| | Amino Acid Motifs | 1 | 2012 | 200 | 0.030 |
Why?
| | Aromatase | 1 | 2011 | 31 | 0.020 |
Why?
| | Erythropoietin | 1 | 1992 | 82 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2011 | 268 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2016 | 1167 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2011 | 422 | 0.020 |
Why?
| | Neurons | 1 | 1997 | 1345 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4077 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 1989 | 162 | 0.020 |
Why?
| | Models, Statistical | 2 | 2004 | 636 | 0.020 |
Why?
| | Family | 1 | 2013 | 585 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2014 | 2478 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 1992 | 359 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2011 | 387 | 0.020 |
Why?
| | Apoptosis | 1 | 1997 | 2484 | 0.020 |
Why?
| | Heart Defects, Congenital | 1 | 2014 | 703 | 0.020 |
Why?
| | Comorbidity | 1 | 2011 | 1527 | 0.020 |
Why?
| | Expressed Sequence Tags | 1 | 2006 | 38 | 0.020 |
Why?
| | Aged | 2 | 2015 | 19657 | 0.020 |
Why?
| | Escherichia coli | 1 | 1989 | 758 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 6561 | 0.010 |
Why?
| | Cohort Studies | 1 | 2014 | 5116 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1989 | 759 | 0.010 |
Why?
| | Africa, Western | 1 | 2003 | 17 | 0.010 |
Why?
| | India | 1 | 2003 | 141 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2003 | 121 | 0.010 |
Why?
| | Conserved Sequence | 1 | 2003 | 219 | 0.010 |
Why?
| | Sweden | 1 | 2001 | 63 | 0.010 |
Why?
| | Sample Size | 1 | 2001 | 133 | 0.010 |
Why?
| | Genetic Linkage | 1 | 2001 | 321 | 0.010 |
Why?
| | Two-Hybrid System Techniques | 1 | 2000 | 58 | 0.010 |
Why?
| | G1 Phase | 1 | 2000 | 68 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 2000 | 138 | 0.010 |
Why?
| | Gene Deletion | 1 | 2001 | 361 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 355 | 0.010 |
Why?
| | Cell Cycle | 1 | 2000 | 550 | 0.010 |
Why?
| | Temperature | 1 | 2000 | 622 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1997 | 181 | 0.010 |
Why?
| | Eye | 1 | 1997 | 106 | 0.010 |
Why?
| | Interleukin-4 | 1 | 1997 | 215 | 0.010 |
Why?
| | Chromatin | 1 | 2000 | 441 | 0.010 |
Why?
| | Defective Viruses | 1 | 1992 | 4 | 0.010 |
Why?
| | Interleukin-3 | 1 | 1992 | 25 | 0.010 |
Why?
| | Receptors, Erythropoietin | 1 | 1992 | 25 | 0.010 |
Why?
| | Gene Expression Regulation, Viral | 1 | 1992 | 84 | 0.010 |
Why?
| | Fluorouracil | 1 | 1992 | 151 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1992 | 653 | 0.010 |
Why?
| | Inflammation | 1 | 1997 | 2566 | 0.000 |
Why?
|
|
Sawyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|